DUGAN MICHAEL C 4
4 · BIOCEPT INC · Filed Oct 5, 2020
Insider Transaction Report
Form 4
BIOCEPT INCBIOC
DUGAN MICHAEL C
Chief Med Off & Med. Director
Transactions
- Award
Employee Stock Option (right to buy)
2020-10-01+69,000→ 69,000 totalExercise: $4.50Exp: 2030-09-30→ Common Stock (69,000 underlying)
Footnotes (1)
- [F1]1/36th of the shares subject to the option shall vest monthly following the Vesting Commencement Date of 10/1/2020 until fully vested on 10/1/2023.